Use of High-Cost Cancer Treatments in Academic and Nonacademic Practice.
Aaron P MitchellAlan C KinlawSharon Peacock-HintonStacie B DusetzinaHanna K SanoffJennifer L LundPublished in: The oncologist (2019)
Oncology care delivery and practice patterns may vary between care settings. By comparing otherwise similar patients treated in National Cancer Institute (NCI)-designated Comprehensive Cancer Centers with those treated elsewhere, this study suggests that patients may be more likely to receive treatment with certain expensive cancer drugs if treated in the non-NCI setting. These practice differences may result in differences in patient costs and outcomes as a result of where they receive treatment.
Keyphrases
- papillary thyroid
- healthcare
- palliative care
- newly diagnosed
- squamous cell
- primary care
- end stage renal disease
- ejection fraction
- chronic kidney disease
- case report
- childhood cancer
- squamous cell carcinoma
- young adults
- skeletal muscle
- adipose tissue
- insulin resistance
- health insurance
- replacement therapy
- glycemic control